← Back to Search

Behavioural Intervention

Audiovisual Stimulation for Hemianopia from Brain Tumors (HHREHAB Trial)

N/A
Waitlist Available
Led By Michael Reber, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to the end of the study at 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a new visual rehabilitation program called Re:Vision for individuals aged 10-40 with hemianopia caused by pediatric brain tumors. The program involves a combination of audio and visual

Who is the study for?
This trial is for individuals aged 10-40 who have hemianopia due to a pediatric brain tumor. Participants will engage in an at-home visual rehabilitation program using virtual reality, and must be able to perform the exercises independently with remote supervision.
What is being tested?
The study tests 'Re:Vision', an 8-week home-based visual telerehabilitation program using audiovisual stimulation in a VR environment. It aims to improve visual perception in those affected by vision loss from brain tumors.
What are the potential side effects?
Since this intervention involves non-invasive audiovisual stimulation, side effects may include discomfort or dizziness related to VR use but are generally expected to be minimal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment to the end of the study at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to the end of the study at 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Binocular Visual Field
Secondary study objectives
Contrast Sensitivity
Fixation Stability
Patient-related Outcome Measures - National Eye Institute - Visual Function Questionnaire - 25
+2 more
Other study objectives
Brain Activity - Visually-evoked potentials
Brain imaging - Retinotopy
Brain imaging - Tractography
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - No InterventionExperimental Treatment1 Intervention
8-week audiovisual stimulation followed by 8-week no intervention
Group II: No Intervention - InterventionActive Control1 Intervention
8-week no intervention followed by 8-week audiovisual stimulation

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,519 Previous Clinical Trials
503,021 Total Patients Enrolled
The Hospital for Sick ChildrenOTHER
708 Previous Clinical Trials
6,958,024 Total Patients Enrolled
Alberta Children's HospitalOTHER
54 Previous Clinical Trials
44,029 Total Patients Enrolled
~33 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top